Artificial Intelligence in Healthcare Diagnosis Market Report 2024 - AI In Healthcare Diagnosis Market Growth, Size And Industry Trends

"The Business Research Company recently released a comprehensive report on the Global Artificial Intelligence in Healthcare Diagnosis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12609&type=smp

According to The Business Research Company's, The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $16.28 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 44.9%. The growth in the historic period can be attributed to advancements in medical imaging, data accessibility and digitization, clinical workflow optimization, research and development investments, shortage of healthcare professionals.

The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $104.32 billion in 2028 at a compound annual growth rate (CAGR) of 45.0%. The growth in the forecast period can be attributed to ai-powered precision medicine, integration with electronic health records, expansion of medical imaging analysis, rise of wearable health tech, regulatory support and standards. Major trends in the forecast period include explainable ai in healthcare, ai-driven early disease detection, telehealth integration, ai in pathology and histopathology, ai-enabled point-of-care diagnostics.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Market Drivers and Trends:
The rising incidence rate of chronic diseases is expected to propel the growth of artificial intelligence in the healthcare diagnosis market going forward. Chronic diseases are long-term health conditions that generally progress slowly over time and often persist intermittently. Artificial Intelligence (AI) in healthcare diagnosis has the potential to significantly impact the management and diagnosis of chronic diseases as it can aid in cost savings and improved resource use. It can help medical practitioners make better decisions, spot patients in danger, and give more individualized care. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising incidence rate of chronic diseases is driving the growth of artificial intelligence in the healthcare diagnosis market.

Technological advancement is a key trend gaining popularity in artificial intelligence in the healthcare diagnosis market. Major companies operating in artificial intelligence in the healthcare diagnosis market are concentrating on creating innovative technologies to sustain their position in the market. For instance, in March 2023, Genomic Vision, a France-based biotechnology company, launched FiberSmart, an AI-powered software to automate detecting and quantifying fluorescent signals on combed DNA (Deoxyribonucleic acid) molecules. FiberSmart offers a simple and user-friendly interface, allowing fast analysis of DNA replication signals to deduce essential parameters describing replication kinetics. Compared to Genomic Vision's current software solutions, the program uses advanced AI techniques to visualize, detect, and evaluate DNA replication kinetics up to three times more accurately and up to ten times faster. FiberSmart's user-friendly interface and ergonomic design enable quick analysis of DNA replication signals to determine crucial variables describing replication kinetics.

Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:
Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation, Medtronic, Nvidia Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Agfa-Gevaert Group, Google Deep Mind, Babylon Health, HeartFlow Inc., Corti HQ, Aidoc, Aidoc Medical Ltd., Imagen Technologies, AliveCor Inc., Digital Diagnostics Inc., Enlitic Inc., NovaSignal Corp., Cleerly Inc., Butterfly Network Inc., IBM Watson Health, Arterys Inc., Caption Health, Zebra Medical Vision Inc., Vuno Inc., Riverain Technologies, CloudMedX Inc., Neural Analytics Inc.

Artificial Intelligence in Healthcare Diagnosis Market 2024 Key Insights:
• The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $104.32 billion in 2028 at a compound annual growth rate (CAGR) of 45.0%.
• Navigating The Rise In Chronic Diseases With Ai-Driven Diagnosis
• Innovations In AI Technologies For Healthcare Diagnosis Leadership
• North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12609&type=smp

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

This release was published on openPR.